A total of 79,645 shares changed hands on the counter till 01:17PM (IST).

This agreement also gains significance of being the first instance when longer-acting injectable products for HIV prevention are being made available to low and middle-income countries.

A total of 51,875 shares changed hands on the counter till 01:27PM (IST).

A total of 40,109 shares changed hands on the counter till 02:04PM (IST).

The stock traded at a P/E multiple of 14.97, while the price-to-book value ratio stood at 1.59.

“Options data suggests a broader trading range in between 16600 to 17300 zones while an immediate trading range in between 16700 to 17150 zones,” Chandan Taparia, Analyst-Derivatives at Motilal Oswal Financial Services Limited, said.

Breakout above its falling 200 DMA after a gap oftwo years adding to the bullish conviction.

Great Eastern Shipping Company shares rose nearly 4 percent to Rs 624 and formed long bullish candlestick pattern on the daily timeframe with above average volumes.

Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 29200.25 Crore) operating in Pharmaceuticals sector.

A total of 23,956 shares changed hands on the counter till 10:05AM (IST).

A total of 35,939 shares changed hands on the counter till time (IST).

On the technical charts, the 200-day moving average of the stock stood at Rs 499.01.

The stock traded at a P/E multiple of 13.93, while the price-to-book value ratio stood at 1.59.

Meanwhile, amid concern over US markets, pharma stocks were also under pressure. Shares of Gland Pharma, Lupin and Granules India declined 2-2.5% in Monday's trade. Aurobindo Pharma, Pfizer, Zydus Lifesciences, GlaxoSmithKline Pharmaceuticals, and Sanofi India were also trading with cuts.

A total of 27,771 shares changed hands on the counter till 10:25AM (IST)

US stocks ended lower Friday as banking shares resumed their selloff, with embattled First Republic Bank closing down 33 percent despite a $30 billion rescue package unveiled Thursday.The Dow Jones Industrial Average ended 1.2 percent lower at 31,861.98 and the broad-based S&P 500 fell 1.1 percent to 3,916.64.

A total of 118,231 shares changed hands on the counter till 10:10AM (IST)

The stock quoted a 52-week high price of Rs 730.0 and a 52-week low of Rs 397.3.

A total of 13,096 shares changed hands on the counter till 10:05AM (IST).

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated February 10, 2023.

The stock quoted a 52-week high price of Rs 730.0 and low of Rs 397.3.

The stock quoted a 52-week high of Rs 730.0 and a 52-week low of Rs 397.3.

The stock quoted a 52-week high price of Rs 730.0 and low of Rs 397.3.

Sharekhan recommended hold rating on Aurobindo Pharma with a target price of Rs 516 in its research report dated February 10, 2023.

A total of 25,185 shares changed hands on the counter till 01:17PM (IST)

The stock quoted a 52-week high price of Rs 730.0 and low of Rs 397.3.

The stock traded at a P/E multiple of 13.49, while the price-to-book value ratio stood at 1.59.

Geojit is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 554 in its research report dated March 02, 2023.

A total of 14,499 shares changed hands on the counter till 12:40PM (IST).

Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 27073.29 Crore) operating in Pharmaceuticals sector.

Wall Street's main indices fell on Wednesday as Treasury yields surged after economic data and comments from policymakers prompted investors to ramp-up expectations of tighter US monetary policy for a prolonged period

A total of 32,563 shares changed hands on the counter till 02:04PM (IST)